Answers are grounded in this paper and cite their sources.
OBJECTIVES: The aim of this study was to adapt the Quality-of-Life Scale in Familial Mediterranean Fever (FMFQoL), a disease-specific quality of life instrument originally developed for adults, in pediatric patients, and to evaluate its validity in children and adolescents diagnosed with Familial Mediterranean fever (FMF). In addition, the study aimed to demonstrate the reliability and applicability of the scale for assessing quality of life in pediatric FMF patients within a large multicenter cohort. METHODS: FMF patients aged 8-18 years who met the Eurofever/PRINTO were included in the study. The adult FMFQoL, in which higher scores indicate poorer quality of life, was adapted for pediatric use through expert review, and subsequently validated in patients from a single center using internal consistency and convergent validity analyses. The reliability and applicability of the pediatric FMFQoL (p-FMFQoL) were examined in a large multicenter cohort, along with its associations with clinical and laboratory findings, and genetic subtypes. RESULTS: The p-FMFQoL demonstrated excellent internal consistency (Cronbach's α = 0.884) and showed a significant negative correlation with the Pediatric Quality of Life Inventory scores, supporting convergent validity (r=-0.495, p < 0.001). In this large multicenter cohort, higher p-FMFQoL scores were significantly associated with female sex, increased attack frequency, elevated acute phase reactants, higher Pras scores, incomplete response to colchicine, and biallelic exon 10 mutations. CONCLUSIONS: This study is the first to adapt and validate the FMFQoL for pediatric use. The p-FMFQoL demonstrated reliability and applicability based on data obtained from a large multicenter cohort.
No takes yet. Share an insight, caveat, or question.
Aydın et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: